ABON PHARMS LLC
GenericsABON PHARMS LLC is a generic drug manufacturer focused on Oncology, Dermatology.
ABON PHARMS LLC's Key Drugs
ABON PHARMS LLC's key approved drugs from the last 15 years (excludes generics, biosimilars and IV formulations).
ABON PHARMS LLC's Recent FDA Approvals
New NDA/BLA approvals for ABON PHARMS LLC over the last two years — novel drugs only, excluding generics and label supplements.
ABON PHARMS LLC's Therapeutic Areas
ABON PHARMS LLC's approved drugs and pipeline span 2 therapeutic areas, led by Oncology and Dermatology. Weighted by commercial stage — approved drugs count most, then late-stage trials.
ABON PHARMS LLC's Top Competitors
ABON PHARMS LLC's closest competitors by therapeutic-area and drug-target overlap include Pfizer, Baxter, and Eli Lilly. Ranked by overlap in therapeutic areas and drug targets across approved drugs and pipeline.
ABON PHARMS LLC Pipeline Snapshot
Active clinical trials for ABON PHARMS LLC across all therapeutic areas, from ClinicalTrials.gov.
Pro Intelligence Preview
Deep insights for investors and analysts
Revenue Insights
- • Top drug revenue breakdown
- • Drug-level revenue analysis
Trial Catalysts
- • Oncology pipeline focus
- • Phase 3 readout tracking
Patent Risk
- • Patent expiration timeline
- • Revenue at risk analysis
Compare Companies
- • Side-by-side pipeline analysis
- • Revenue & market share comparison
Revenue forecasts • Trial milestones • Patent risk modeling
Active (0)
Discontinued (0)
Company Info
- First Approval
- 2017-05-09
- Latest
- 2025-09-23
- Applications
- 5